December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Jarushka Naidoo: Can a cfDNA fragmentomic assay assist in lung cancer screening?
Jun 12, 2024, 05:36

Jarushka Naidoo: Can a cfDNA fragmentomic assay assist in lung cancer screening?

Jarushka Naidoo shared on X/Twitter:

“Can a cfDNA fragmentomic assay assist in lung cancer screening?

– prospective case-control study in >900 patients
– 84% sensitivity, across stages
– (+LDCT) = decreased no. needed to screen to just 76

Next step validate in prospective cohorts.”

Image

Visit the article website.
Source: Jarushka Naidoo/X

Dr. Jarushka Naidoo is a thoracic oncologist at the Beaumont Hospital Dublin (Ireland), Professor in RCSI and Adjunct Professor of Oncology at Johns Hopkins University.

She currently serves as national lung cancer lead for Cancer Trials Ireland. She serves on several international guideline panels including ASCO and SITC (Society of Immunotherapy for Cancer), and is an experienced clinical trialist- having developed and completed several investigator-initiated, industry-funded and cooperative group clinical trials.

She has received a number of grants including a young investigator award from the International Association for the Study of Lung Cancer (IASLC), Lung Cancer Foundation of America (LCFA), and a career development award from the National Institutes of Health (NIH) KL2-program. She is the IASLC Communications Committee Chair.